Federal Data Show Opioid Toxicity Deaths Continue at Crisis Levels Across Canada as Fentanyl Drives the Toll

Federal public-health data show that opioid toxicity continued to claim Canadian lives at crisis levels through the first nine months of 2025, with 4,162 apparent opioid toxicity deaths recorded across the country, ninety-six per cent of them accidental, and with British Columbia, Alberta, and Ontario accounting for seventy-eight per cent of all deaths. The numbers, drawn from the most recent comprehensive federal release on opioid and stimulant-related harms and the most current data available as of April, place the total Canadian toll from opioid toxicity since 2016 at more than 55,000 lives, a figure that public-health officials have described as one of the largest non-pandemic mortality crises in Canadian history.

What the data show

The Public Health Agency of Canada's substance-related harms surveillance system tracks apparent opioid toxicity deaths across all provinces and territories. The most recent release covers the period from January 2016 through September 2025. The cumulative national death toll over that period is 55,032. The first nine months of 2025 produced 4,162 deaths, a daily average of approximately fifteen Canadians lost to opioid toxicity.

The 2025 figure is broadly consistent with the trajectory of the past three years, in which annual death tolls have been substantially higher than pre-pandemic levels and have not shown a sustained decline despite a wide range of public-health interventions, harm reduction expansions, and treatment investments. The continued elevated mortality has been a consistent challenge for federal, provincial, and municipal public-health authorities across the country.

The federal data also track emergency medical services responses to suspected opioid-related overdoses. The first nine months of 2025 produced 28,084 EMS responses across the country, on top of a cumulative figure of 272,875 responses since 2017. The EMS response data represent a small fraction of total overdose events, since not all overdoses result in emergency medical responses, but provide an important indicator of overdose severity in communities where the data are reported.

Demographics and drug involvement

The demographics of opioid toxicity deaths have remained consistent across recent years. Seventy-four per cent of deaths in the first nine months of 2025 occurred among males. The most affected age groups were people aged thirty to thirty-nine, who accounted for twenty-six per cent of deaths, and people aged forty to forty-nine, who accounted for twenty-five per cent. The pattern has been consistent across recent years and reflects the way that substance use, opioid dependence, and overdose risk are distributed across the Canadian population.

The drug involvement data show that fentanyl continues to be the dominant driver of the crisis. Fifty-eight per cent of all opioid toxicity deaths in the first nine months of 2025 involved fentanyl, and fifty-seven per cent involved fentanyl analogues. The proliferation of fentanyl and increasingly potent fentanyl analogues across the unregulated drug supply has been the central driver of the elevated mortality across the past several years.

The increasing presence of stimulants in the unregulated drug supply, often in combination with opioids, has added complexity to the crisis. Polysubstance use, in which people use multiple substances either intentionally or because of contamination, has been associated with increased overdose risk and with more challenging clinical presentations for emergency responders.

Provincial differences

The provincial distribution of opioid toxicity deaths shows significant variation. British Columbia continues to have one of the highest per-capita death rates in the country, with Vancouver, the Lower Mainland, and the Interior all heavily affected. Alberta has seen elevated deaths particularly in Calgary and Edmonton. Ontario's high absolute death count reflects the province's larger population, although per-capita rates are typically lower than in British Columbia or Alberta.

Quebec has had a different epidemic profile, with lower per-capita opioid toxicity death rates than the western provinces. Researchers have attributed the difference to a combination of differences in drug supply, in service delivery models, and in the structure of the unregulated drug market. The Atlantic provinces and the territories have generally had lower death counts in absolute terms, although per-capita rates in some smaller jurisdictions have been comparable to those in larger provinces.

The provincial differences have shaped policy responses. British Columbia's drug decriminalisation pilot, which was scaled back in 2024, has been the most prominent provincial policy experiment. Alberta has emphasised treatment expansion and has implemented additional restrictions on certain harm-reduction programmes. Ontario has expanded supervised consumption services and has invested in treatment expansion.

Federal response

The federal response to the opioid crisis has spanned multiple tracks across the past decade. Health Canada has continued to support provincial and territorial harm-reduction services, supervised consumption sites, and naloxone distribution. Indigenous Services Canada has invested in Indigenous-led mental health and addictions programming, recognising the disproportionate impact of the crisis on Indigenous communities.

The Carney government's spring economic update included additional funding for community-based mental health and substance use services, although the specific allocations and programme designs are still being developed. Federal officials have emphasised that response to the crisis requires sustained investment in primary care, in mental health services, in housing, and in the broader social determinants of health rather than relying solely on emergency response and harm-reduction services.

The federal Minister of Mental Health and Addictions has been working with provincial and territorial counterparts on coordinated response strategies. The minister has emphasised that the crisis cannot be addressed by any single level of government acting alone and has called for sustained federal-provincial-territorial collaboration on the file.

Indigenous communities

Indigenous communities have been disproportionately affected by the opioid crisis. First Nations, Inuit, and Metis populations have experienced higher per-capita opioid toxicity death rates than the broader Canadian population in many jurisdictions. The reasons are complex and include intergenerational trauma associated with the residential school system and other colonial policies, limited access to mental health and addiction services in many communities, and the broader social and economic conditions that affect health outcomes.

Indigenous-led responses to the crisis have included community-based wellness programmes, on-the-land and culturally grounded treatment models, harm-reduction services delivered in culturally appropriate ways, and significant investment in mental health services that integrate clinical and cultural approaches. The Assembly of First Nations and other Indigenous organisations have called for sustained federal investment in these approaches and for recognition of Indigenous jurisdiction over health services in many communities.

The unregulated drug supply

The driver behind the elevated mortality has been the changing composition of the unregulated drug supply. Fentanyl and its analogues have replaced heroin in many regional markets, and the potency of the unregulated supply has grown more variable and more dangerous over time. People who use opioids face significantly higher overdose risk today than they did a decade ago, even when their patterns of use have remained the same.

Drug checking services, which allow people to have substances tested before use, have been an important harm-reduction tool. Naloxone, which can reverse an opioid overdose if administered in time, has been distributed widely. Supervised consumption services have prevented deaths and connected people with treatment and other services. The cumulative effect of these tools has been to limit the death toll, although the underlying drivers of the crisis have not been resolved.

Treatment and recovery

Beyond harm reduction, treatment and recovery infrastructure has been expanded across recent years. Opioid agonist therapy, including methadone and buprenorphine, has become more accessible in many regions. Residential treatment programmes have been expanded in some jurisdictions, although waitlists in some provinces remain significant. Long-term recovery support, including housing-first programmes, peer support, and employment supports, has been expanded.

Despite the expansion of services, gaps remain. Many Canadians who would benefit from treatment cannot access it because of waitlists, geographic barriers, or other access issues. Continuity of care between hospital, community, and residential settings remains uneven. Cultural and linguistic competence in services for Indigenous, immigrant, and other communities has been improving but remains a continuing area of work.

What's next

The Public Health Agency of Canada is expected to release updated quarterly data through the year. Provincial chief medical officers of health are continuing to publish provincial data on overdose deaths and EMS responses. Federal, provincial, and territorial ministers responsible for mental health and addictions are expected to meet in the coming months to discuss coordinated response strategies.

For Canadians watching the broader public-health picture, the data confirm what front-line workers, families, and affected communities have been saying for several years. The crisis has not abated. Lives continue to be lost at rates that the country has never before sustained over a comparable period. The work required to bring the crisis under control has not yet succeeded at the scale required, although elements of progress are visible in some communities and on some specific dimensions.

For policymakers, the question is whether the response of the past decade has been adequate to the scale of the problem and whether more transformative interventions are required. The conversation continues across federal, provincial, territorial, municipal, and community jurisdictions, with significant disagreement about specific policy choices but with broad agreement that the status quo cannot continue indefinitely.